{"id":"https://openalex.org/W2066348591","doi":"https://doi.org/10.1002/acr.20088","title":"Medicare reimbursement and the use of biologic agents: Incentives, access, the public good, and optimal care","display_name":"Medicare reimbursement and the use of biologic agents: Incentives, access, the public good, and optimal care","publication_year":2010,"publication_date":"2010-01-22","ids":{"openalex":"https://openalex.org/W2066348591","doi":"https://doi.org/10.1002/acr.20088","mag":"2066348591","pmid":"https://pubmed.ncbi.nlm.nih.gov/20391473","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3018780"},"language":"en","primary_location":{"id":"doi:10.1002/acr.20088","doi":"https://doi.org/10.1002/acr.20088","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.20088","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care & Research","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3018780","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052860753","display_name":"Michael M. Ward","orcid":"https://orcid.org/0000-0003-1857-9367","observed_orcids":["https://orcid.org/0000-0003-1857-9367"]},"institutions":[{"id":"https://openalex.org/I4210087962","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael M. Ward","raw_affiliation_strings":["National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210087962"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052860753"],"corresponding_institution_ids":["https://openalex.org/I4210087962"],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"62","issue":"3","first_page":"293","last_page":"295"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.16500000655651093,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medicare-reimbursement","display_name":"Medicare reimbursement","score":0.7829999923706055},{"id":"https://openalex.org/keywords/biologic-agents","display_name":"biologic agents","score":0.8980000019073486},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8840000033378601},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.9620000123977661},{"id":"https://openalex.org/keywords/medicare-part-b","display_name":"Medicare Part B","score":0.7200000286102295},{"id":"https://openalex.org/keywords/average-wholesale-price","display_name":"average wholesale price","score":0.7289999723434448},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.7070000171661377},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9539999961853027},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.3190000057220459},{"id":"https://openalex.org/keywords/reimbursement-incentives","display_name":"reimbursement incentives","score":0.43299999833106995},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.3100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9180164337158203},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.9113374948501587},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.7603765726089478},{"id":"https://openalex.org/C2780265253","wikidata":"https://www.wikidata.org/wiki/Q1416012","display_name":"Managed care","level":3,"score":0.4902356266975403},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4234089255332947},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.39503413438796997},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.3526882529258728},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.1863156259059906},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.10487264394760132},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001685","descriptor_name":"Biological Factors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012052","descriptor_name":"Reimbursement, Incentive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016345","descriptor_name":"Medicare Part B","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019985","descriptor_name":"Benchmarking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054524","descriptor_name":"Medicare Part D","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/acr.20088","doi":"https://doi.org/10.1002/acr.20088","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.20088","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care & Research","raw_type":"journal-article"},{"id":"pmid:20391473","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20391473","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis care & research","raw_type":"Comment"},{"id":"pmh:oai:pubmedcentral.nih.gov:3018780","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3018780","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Arthritis Care Res (Hoboken)","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3018780","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3018780","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Arthritis Care Res (Hoboken)","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1120722310","display_name":"Outcomes in Rheumatic Diseases","funder_award_id":"ZIAAR041153","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G7281753780","display_name":"Outcomes in Rheumatic Diseases","funder_award_id":"Z01AR041153","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G7345425041","display_name":"Rheumatic and Autoimmune Diseases in Minority Communities","funder_award_id":"Z01AR041170","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G9000875745","display_name":"Studies of the Natural History of Rheumatic Diseases","funder_award_id":"ZIAAR041170","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W159282500","https://openalex.org/W1489953053","https://openalex.org/W1990713219","https://openalex.org/W1999306257","https://openalex.org/W2021346173","https://openalex.org/W2033532197","https://openalex.org/W2041938544","https://openalex.org/W2051317937","https://openalex.org/W2158472072","https://openalex.org/W2159901364","https://openalex.org/W2162254515","https://openalex.org/W2168415188"],"related_works":["https://openalex.org/W1486433779","https://openalex.org/W1663243338","https://openalex.org/W2102273617","https://openalex.org/W1993544971","https://openalex.org/W2804500957","https://openalex.org/W2306808229","https://openalex.org/W1990713219","https://openalex.org/W2021346173","https://openalex.org/W2420757759","https://openalex.org/W2210415926"],"abstract_inverted_index":{"The":[0,278,350,506,679,770,932,1141],"Medicare":[1,32,98,130,204,343,392,587,666,689,928,959,1044,1077,1246],"Prescription":[2],"Drug":[3],"Improvement":[4],"and":[5,64,123,179,189,229,250,266,286,315,321,325,339,358,394,420,463,497,575,661,671,697,724,730,762,786,821,1150,1179,1210,1243,1285,1294,1379,1461],"Modernization":[6],"Act":[7],"of":[8,31,47,89,111,114,147,150,182,193,213,231,333,398,432,509,541,547,621,637,643,655,688,695,703,708,710,715,734,744,772,830,850,861,889,908,1024,1068,1076,1089,1099,1116,1118,1176,1187,1241,1269,1281,1292,1301,1312,1346,1356,1394],"2003":[9,340],"(MMA)":[10],"represented":[11],"the":[12,17,19,26,29,41,44,84,112,118,148,166,177,191,209,214,225,233,237,246,251,255,271,331,365,381,399,406,415,430,434,449,539,542,545,565,584,592,613,619,632,652,658,673,692,701,706,732,742,758,801,806,810,831,847,859,877,884,919,925,938,951,971,1021,1037,1057,1066,1074,1087,1105,1114,1125,1128,1135,1144,1172,1180,1194,1201,1220,1239,1261,1267,1279,1290,1298,1303,1310,1329,1337,1344,1357,1371,1392,1407,1424],"most":[13,37,1408],"important":[14,1299,1409],"change":[15,1342,1414],"in":[16,33,79,106,260,284,352,379,405,467,515,618,657,700,717,783,791,803,823,838,866,872,879,892,923,927,940,960,1011,1015,1020,1042,1055,1101,1113,1174,1264,1309,1340,1398],"way":[18],"federal":[20,382],"government":[21,383],"supports":[22],"medical":[23],"care":[24,636,1430],"for":[25,43,55,74,83,257,280,307,424,454,597,727,765,805,818,887,956,1171,1208,1229,1318,1363,1382,1431],"elderly":[27,85],"since":[28],"inception":[30],"1965.":[34],"Among":[35],"its":[36,60,569],"significant":[38],"provisions":[39],"was":[40,96,220,282,292,371,439,921,975,1108,1168],"establishment":[42],"first":[45,653],"time":[46],"a":[48,76,268,293,300,440,444,580,616,684,779,843,856,980,1097,1110,1119,1205,1307,1341],"benefit":[49,837],"program,":[50],"known":[51],"as":[52,198,944],"Part":[53,69,94,172,832,893,1249,1369],"D,":[54,1370],"outpatient":[56,115,163,482,834],"prescription":[57,835],"drugs.":[58],"Despite":[59],"deductibles,":[61],"doughnut":[62],"holes,":[63],"dizzying":[65],"differences":[66,244],"among":[67,461,532,550,665,825],"formularies,":[68],"D":[70,95,833,894,1250],"has":[71,175,554,567,578,606,1305],"been":[72,530,556,579,964,1198],"lauded":[73],"redressing":[75],"major":[77],"omission":[78],"health":[80,1463],"insurance":[81,142],"coverage":[82,888,1367],"(1,":[86],"2).":[87],"As":[88],"January":[90,127],"1,":[91,128],"2006,":[92,129,1086,1289],"when":[93],"implemented,":[97],"patients":[99,131,344,488,533,551,598,638,745,773,862,899,1147,1188,1209,1230,1270,1319,1384,1432],"with":[100,165,190,487,534,552,599,639,668,749,775,995,1006,1080,1231,1271,1320,1433],"rheumatoid":[101],"arthritis":[102],"(RA)":[103],"could":[104,275,317,327,1257],"enroll":[105],"plans":[107],"to":[108,126,136,202,227,299,373,385,389,411,436,472,475,491,500,520,562,601,610,755,876,900,1029,1063,1085,1124,1217,1227,1273,1427,1442,1450],"cover":[109,145],"part":[110,146],"costs":[113,167,181,226,253,733],"medications,":[116,1349],"including":[117,187,729],"self-injectable":[119,151,890,1372],"biologic":[120,152,194,548,603,622,1275,1313,1373,1443],"agents":[121,549,604,1374,1444],"etanercept":[122,1242],"adalimumab.":[124],"Prior":[125,201],"had":[132,297,377,429,568,948],"two":[133],"primary":[134],"means":[135],"access":[137,298,499,602,609,1062,1226,1268,1441,1449],"biologics:":[138],"buy":[139],"supplemental":[140],"private":[141],"that":[143,243,270,342,368,375,408,465,480,498,523,627,741,883,918,937,974,1036,1051,1073,1184,1219,1315,1326],"would":[144,309,469,484,502,962,1222,1351],"cost":[149],"agents,":[153,195],"or":[154,161,273,474,571,605,852,868,903,1060,1107,1156],"receive":[155,492],"infliximab":[156,199,281,347,664,704,711,716,750,766,776,851,865,871,957,1007,1025,1081,1177,1203,1228,1327,1387],"at":[157,494,778,950],"their":[158,323,905],"physician's":[159],"office":[160],"hospital":[162,274,481],"department,":[164],"largely":[168,528,813],"paid":[169],"by":[170,185,236,417,768,809,815,934,958,1104,1200,1245,1360,1402],"Medicare.\r\n\r\nMedicare":[171],"B":[173],"traditionally":[174],"covered":[176],"medication":[178,807,1121],"administration":[180,820],"treatments":[183,501,902],"given":[184],"infusion,":[186],"chemotherapy,":[188],"advent":[192],"medications":[196,259,1453],"such":[197],"(3).":[200],"2004,":[203],"reimbursements":[205,453],"were":[206,262,355,363,403,422,458,747,812,874,942,1161,1189,1251,1458],"based":[207],"on":[208,544,589,683,846,930,1046,1238,1278,1440,1447],"average":[210,247,1022],"wholesale":[211,248],"price":[212,249,334],"drug":[215,455,735,819,836],"(the":[216],"list":[217],"price),":[218],"which":[219,306,418,438],"often":[221],"substantially":[222],"higher":[223,816],"than":[224,794,966,970],"physicians":[228,314,419],"hospitals":[230,316,421],"acquiring":[232],"drug.":[234],"Audits":[235],"US":[238,356],"Government":[239],"Accountability":[240],"Office":[241],"reported":[242,740],"between":[245,264,337,1146],"acquisition":[252],"(i.e.,":[254],"spread)":[256],"infused":[258],"2001":[261,287],"commonly":[263],"15%":[265],"30%,":[267],"difference":[269],"physician":[272,495],"keep":[276],"(4).":[277],"spread":[279,435],"32%":[283],"1999":[285],"(5).\r\n\r\nIn":[288],"many":[289,308,898,1383],"ways,":[290],"this":[291,353,641,978,1096,1109,1132,1255,1350],"win-win-win":[294],"situation.":[295],"Patients":[296,1158],"valuably":[301],"effective":[302],"but":[303,443,1001,1445],"expensive":[304],"medication,":[305],"not":[310,489,529,555,841,896,1040,1169,1190,1252,1258,1437],"otherwise":[311],"be":[312,485,503,1405],"available;":[313],"provide":[318],"needed":[319,1234],"treatment":[320,493,1149,1152],"increase":[322,1019,1090],"incomes;":[324],"companies":[326],"sell":[328],"more":[329,629,965,1347],"without":[330,1286],"worry":[332],"controls.":[335],"Surveys":[336],"1998":[338],"confirmed":[341],"preferentially":[345],"used":[346],"(6,":[348],"7).":[349],"losers":[351],"scenario":[354],"taxpayers":[357],"businesses":[359],"who,":[360],"through":[361],"Medicare,":[362],"paying":[364],"bill.":[366],"Recognizing":[367],"each":[369],"actor":[370],"responding":[372],"incentives":[374,388,1195,1381],"it":[376,577,595,607,1048,1052,1417],"put":[378],"place,":[380],"sought":[384],"reduce":[386],"these":[387,513,524,1164,1274],"help":[390],"control":[391],"spending":[393,588,929,1045,1054],"exert":[395],"better":[396,1459],"stewardship":[397],"public's":[400],"money.":[401,1364],"Provisions":[402],"included":[404],"MMA":[407,450,543,566,585,593,614,633,674,759,811,920,1038,1058,1221,1304,1338,1425],"from":[409,753,983,1026,1083,1163],"2004":[410],"2006":[412,839,867,873,961,1265],"sequentially":[413],"changed":[414],"standard":[416],"reimbursed":[423],"infusion":[425,478],"treatments.":[426],"These":[427],"changes":[428,656,1100,1397],"effect":[431,677,845],"reducing":[433,1043],"6\u20138%,":[437],"lower":[441],"mark-up,":[442],"mark-up":[445],"nonetheless":[446],"(8).":[447],"Although":[448,977,1032,1065,1127,1193],"also":[451,511,997],"increased":[452,751,767,777,989,998,1082,1266],"administration,":[456],"there":[457,1213],"concerns,":[459],"primarily":[460],"hematologists":[462],"oncologists,":[464],"reductions":[466,939],"payments":[468,726,764,788,797,804,817,947,955,987,1002],"cause":[470],"practices":[471],"close":[473],"stop":[476],"providing":[477],"treatments,":[479],"departments":[483],"overwhelmed":[486],"able":[490],"offices,":[496],"reduced":[504,586,1199],"(9).":[505],"American":[507],"College":[508],"Rheumatology":[510],"presented":[512],"concerns":[514],"Congressional":[516],"hearings":[517],"(10).\r\n\r\nLimited":[518],"evidence":[519,1137],"date":[521],"suggests":[522,1138],"potential":[525],"problems":[526],"have":[527,842,963,1197,1223,1324,1375],"realized":[531],"cancer":[535],"(11,":[536],"12).":[537],"However,":[538,1365],"impact":[540],"use":[546,659,849,1117,1240,1280,1345],"RA":[553,600,669,996,1232,1272,1434],"explored.":[557],"Four":[558],"key":[559],"questions":[560],"arise":[561],"determine":[563,1259],"if":[564,576,1260,1423],"intended,":[570],"any":[572,1412],"unintended":[573],"consequences,":[574],"wise":[581],"policy.":[582],"Has":[583,591,612,631],"infliximab?":[590],"made":[594],"easier":[596],"limited":[608,1059,1225],"biologics?":[611,1064],"induced":[615,1306],"shift":[617,1308],"type":[620,1311],"agent":[623,1314],"prescribed":[624,1317],"toward":[625,1343],"those":[626,826],"are":[628],"cost-effective?":[630],"promoted":[634],"optimal":[635,1429],"RA?\r\n\r\nIn":[640],"issue":[642],"Arthritis":[644],"Care":[645],"&":[646],"Research,":[647],"Doshi":[648,737,1069,1293],"et":[649,738,1070],"al":[650,739,1071],"report":[651],"analysis":[654,933,1067,1256,1291],"of,":[660],"expenditures":[662],"for,":[663],"beneficiaries":[667,690,1078,1247],"before":[670,757],"after":[672,1093,1122,1288],"went":[675],"into":[676],"(13).":[678],"authors":[680],"abstracted":[681],"data":[682,1129,1237,1277,1287,1439],"5%":[685],"random":[686],"sample":[687],"over":[691,990,999],"transition":[693],"period":[694],"2002\u20132006,":[696],"examined":[698],"trends":[699],"number":[702,707,743,771,1075],"users,":[705],"units":[709],"dispensed":[712],"(1":[713],"unit":[714],"Medicare's":[718,1354],"accounting":[719],"system":[720],"=":[721],"10":[722],"mg),":[723],"total":[725,763,787,796,853,954,986],"infliximab,":[728,1047],"excluding":[731],"administration.":[736],"who":[746,863,869,1159,1233],"treated":[748,774,1005,1079],"sharply":[752],"2002":[754,952,1012,1084],"2003,":[756],"took":[760],"effect,":[761],"39%.":[769],"much":[780],"slower":[781],"pace":[782],"subsequent":[784],"years,":[785,881],"leveled":[789],"off":[790],"2005\u20132006.":[792],"Rather":[793],"decreasing,":[795],"remained":[798,949,1008,1204],"stable":[799,1009],"because":[800],"decreases":[802],"imposed":[808],"offset":[814],"increases":[822],"dose":[824,1023],"receiving":[827],"infliximab.":[828,931,1192],"Introduction":[829],"did":[840,895,1039],"demonstrable":[844],"overall":[848],"payments.":[854],"In":[855],"longitudinal":[857,1181],"analysis,":[858],"proportions":[860,878],"discontinued":[864],"started":[870],"similar":[875],"previous":[880],"suggesting":[882],"new":[885,1120],"benefits":[886,1263],"biologics":[891],"induce":[897],"switch":[901],"alter":[904],"initial":[906],"choice":[907],"tumor":[909],"necrosis":[910],"factor":[911],"\u03b1":[912],"(TNF\u03b1)":[913],"inhibitor.\r\n\r\nThese":[914],"results":[915],"convincingly":[916],"demonstrate":[917],"successful":[922],"limiting":[924],"rise":[926],"quarter-year":[935],"demonstrates":[936],"payment":[941],"implemented":[943],"designed.":[945],"If":[946,1336],"rate,":[953],"$708":[967],"million,":[968],"rather":[969],"$537":[972],"million":[973],"paid.":[976],"represents":[979,1143],"31%":[981],"decrease":[982],"projected":[984],"expenditures,":[985],"still":[988,1385],"time.":[991],"Payments":[992],"per":[993,1003],"patient":[994,1004],"time,":[1000],"($13,218":[1010],"versus":[1013],"$13,543":[1014],"2006),":[1016],"despite":[1017,1366],"an":[1018],"338":[1027],"mg/infusion":[1028],"401":[1030],"mg/infusion.":[1031],"critics":[1033],"might":[1034,1196],"argue":[1035],"succeed":[1041],"is":[1049,1214,1316,1328,1415],"clear":[1050],"held":[1053],"check.\r\n\r\nHas":[1056],"facilitated":[1061],"indicates":[1072],"rate":[1088,1115],"slowed":[1091],"dramatically":[1092],"2003.":[1094],"Was":[1095],"consequence":[1098],"reimbursement":[1102,1399],"stipulated":[1103],"MMA,":[1106,1202],"natural":[1111,1139],"settling":[1112],"introduction":[1123],"market?":[1126],"cannot":[1130,1296],"answer":[1131],"question":[1133,1300,1393,1410],"definitively,":[1134],"circumstantial":[1136],"causes.":[1140],"prevalence":[1142],"balance":[1145],"entering":[1148],"leaving":[1151],"(through":[1153],"either":[1154],"discontinuation":[1155],"death).":[1157],"died":[1160],"excluded":[1162],"analyses,":[1165],"so":[1166,1212,1254],"mortality":[1167],"responsible":[1170],"slowdown":[1173],"growth":[1175],"use,":[1178],"analyses":[1182],"suggested":[1183],"large":[1185],"numbers":[1186],"discontinuing":[1191],"win-win":[1206],"situation":[1207],"physicians,":[1211],"little":[1215],"reason":[1216],"suspect":[1218],"directly":[1224],"it.":[1235],"Unfortunately,":[1236],"adalimumab":[1244],"under":[1248,1368],"available,":[1253],"expanded":[1262],"agents.\r\n\r\nWithout":[1276],"other":[1282,1451],"TNF\u03b1":[1283,1332],"inhibitors,":[1284],"colleagues":[1295],"address":[1297],"whether":[1302,1395,1416,1448,1455,1462],"RA.":[1321],"Several":[1322],"studies":[1323],"concluded":[1325],"least":[1330],"cost-effective":[1331,1348],"inhibitor":[1333],"(14,":[1334],"15).":[1335],"resulted":[1339],"further":[1352,1396],"enhance":[1353],"protection":[1355],"public":[1358],"good":[1359],"emphasizing":[1361],"value":[1362],"high":[1376],"out-of-pocket":[1377],"expenses,":[1378],"financial":[1380],"favor":[1386],"(16).":[1388],"This":[1389],"leaves":[1390],"open":[1391],"policy":[1400,1413],"guided":[1401],"cost-effectiveness":[1403],"will":[1404,1435],"forthcoming.\r\n\r\nUltimately,":[1406],"regarding":[1411],"improves":[1418],"patients'":[1419],"lives.":[1420],"To":[1421],"know":[1422],"helped":[1426],"promote":[1428],"require":[1436],"only":[1438],"information":[1446],"antirheumatic":[1452],"increased,":[1454],"comorbid":[1456],"conditions":[1457],"controlled,":[1460],"outcomes":[1464],"improved.":[1465]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}